Colon Cancer Home > Erbitux Chemotherapy Information

Erbitux® (cetuximab) is a drug used in the treatment of squamous cell carcinoma of the head and neck, as well as advanced colorectal cancer (cancer of the colon and rectum) that expresses a protein called epidermal growth factor receptor (EGFR). It can be used alone or in combination with other treatments as part of a person's chemotherapy regimen.
A healthcare provider will administer Erbitux by injection once a week. Prior to beginning treatment with this medication, review the safety information for Erbitux with your healthcare provider. For example, it's important to limit your time in the sun and wear protective clothing and sunscreen during treatment. In addition, report any rashes, swelling, or anything else that "just does not seem right" to your healthcare provider.
(Click Erbitux for more information on this chemotherapy drug, including how it works, dosing guidelines, and what to do if you are pregnant or breastfeeding.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.